Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration

被引:0
|
作者
Dayong Lee
Ryan Vandrey
Garry Milman
Mateus Bergamaschi
Damodara R. Mendu
Jeannie A. Murray
Allan J. Barnes
Marilyn A. Huestis
机构
[1] Chemistry and Drug Metabolism,
[2] Intramural Research Program,undefined
[3] National Institute on Drug Abuse,undefined
[4] NIH,undefined
[5] Biomedical Research Center,undefined
[6] Johns Hopkins University School of Medicine,undefined
[7] Behavioral Biology Research Center,undefined
来源
关键词
Cannabis; Marijuana; Delta9-tetrahydrocannabinol; Oral fluid; Plasma; Ratio;
D O I
暂无
中图分类号
学科分类号
摘要
Oral fluid (OF) is a valuable biological alternative for clinical and forensic drug testing. Evaluating OF to plasma (OF/P) cannabinoid ratios provides important pharmacokinetic data on the disposition of drug and factors influencing partition between matrices. Eleven chronic cannabis smokers resided on a closed research unit for 51 days. There were four 5-day sessions of 0, 30, 60, and 120 mg oral ∆9-tetrahydrocannabinol (THC)/day followed by a five-puff smoked cannabis challenge on Day 5. Each session was separated by 9 days ad libitum cannabis smoking. OF and plasma specimens were analyzed for THC and metabolites. During ad libitum smoking, OF/P THC ratios were high (median, 6.1; range, 0.2–348.5) within 1 h after last smoking, decreasing to 0.1–20.7 (median, 2.1) by 13.0–17.1 h. OF/P THC ratios also decreased during 5-days oral THC dosing, and after the smoked cannabis challenge, median OF/P THC ratios decreased from 1.4 to 5.5 (0.04–245.6) at 0.25 h to 0.12 to 0.17 (0.04–5.1) at 10.5 h post-smoking. In other studies, longer exposure to more potent cannabis smoke and oromucosal cannabis spray was associated with increased OF/P THC peak ratios. Median OF/P 11-nor-9-carboxy-THC (THCCOOH) ratios were 0.3–2.5 (range, 0.1–14.7) ng/μg, much more consistent in various dosing conditions over time. OF/P THC, but not THCCOOH, ratios were significantly influenced by oral cavity contamination after smoking or oromucosal spray of cannabinoid products, followed by time-dependent decreases. Establishing relationships between OF and plasma cannabinoid concentrations is essential for making inferences of impairment or other clinical outcomes from OF concentrations.
引用
收藏
页码:7269 / 7279
页数:10
相关论文
共 50 条
  • [1] Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration
    Lee, Dayong
    Vandrey, Ryan
    Milman, Garry
    Bergamaschi, Mateus
    Mendu, Damodara R.
    Murray, Jeannie A.
    Barnes, Allan J.
    Huestis, Marilyn A.
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2013, 405 (23) : 7269 - 7279
  • [2] Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration
    Swortwood, Madeleine J.
    Newmeyer, Matthew N.
    Andersson, Maria
    Abulseoud, Osama A.
    Scheidweiler, Karl B.
    Huestis, Marilyn A.
    [J]. DRUG TESTING AND ANALYSIS, 2017, 9 (06) : 905 - 915
  • [3] Cannabinoid Disposition in Oral Fluid after Controlled Smoked Cannabis
    Lee, Dayong
    Schwope, David M.
    Milman, Garry
    Barnes, Allan J.
    Gorelick, David A.
    Huestis, Marilyn A.
    [J]. CLINICAL CHEMISTRY, 2012, 58 (04) : 748 - 756
  • [4] Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers
    Sebastien Anizan
    Garry Milman
    Nathalie Desrosiers
    Allan J. Barnes
    David A. Gorelick
    Marilyn A. Huestis
    [J]. Analytical and Bioanalytical Chemistry, 2013, 405 : 8451 - 8461
  • [5] Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers
    Anizan, Sebastien
    Milman, Garry
    Desrosiers, Nathalie
    Barnes, Allan J.
    Gorelick, David A.
    Huestis, Marilyn A.
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2013, 405 (26) : 8451 - 8461
  • [6] On-site oral fluid Δ9-tetrahydrocannabinol (THC) screening after controlled smoked, vaporized, and oral cannabis administration
    Madeleine J. Swortwood
    Matthew N. Newmeyer
    Osama A. Abulseoud
    Maria Andersson
    Allan J. Barnes
    Karl B. Scheidweiler
    Marilyn A. Huestis
    [J]. Forensic Toxicology, 2017, 35 : 133 - 145
  • [7] On-site oral fluid Δ9-tetrahydrocannabinol (THC) screening after controlled smoked, vaporized, and oral cannabis administration
    Swortwood, Madeleine J.
    Newmeyer, Matthew N.
    Abulseoud, Osama A.
    Andersson, Maria
    Barnes, Allan J.
    Scheidweiler, Karl B.
    Huestis, Marilyn A.
    [J]. FORENSIC TOXICOLOGY, 2017, 35 (01) : 133 - 145
  • [8] Impact of oral fluid collection device on cannabinoid stability following smoked cannabis
    Anizan, Sebastien
    Bergamaschi, Mateus M.
    Barnes, Allan J.
    Milman, Garry
    Desrosiers, Nathalie
    Lee, Dayong
    Gorelick, David A.
    Huestis, Marilyn A.
    [J]. DRUG TESTING AND ANALYSIS, 2015, 7 (02) : 114 - 120
  • [9] Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis
    Milman, Garry
    Schwope, David M.
    Gorelick, David A.
    Huestis, Marilyn A.
    [J]. CLINICA CHIMICA ACTA, 2012, 413 (7-8) : 765 - 770
  • [10] Relationship of Δ9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis
    Huestis, MA
    Cone, EJ
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 2004, 28 (06) : 394 - 399